BIG for LIFE® - Effects of LSVT BIG® group therapy on physical functions and subjective perception in patients with Parkinson's disease (H&Y 1-4)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022919

Enrollment

Registered

2021-04-26

Start date

2021-01-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20

Interventions

Group 1: Patients with Parkinson's (Hoehn & Yahr 1-4), BIG for LIFE, specific group therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with Parkinson's disease, completed 4-week LSVT-BIG therapy, Hoehn & Yahr: 1-4

Exclusion criteria

Exclusion criteria: Severe Cardiovascular Disease (NYHA 3-4), Acute Severe Infectious Diseases, Fresh Fractures, Severe Dementia, Orthostatic Hypotension, New, Unexplained Neurological Signs and Symptoms

Design outcomes

Primary

Measure	Time frame
Before and after the 6-week group therapy: mobility measured using the timed-up and go test, strength measured using the chair rising test and motor functions measured using the Unified Parkinson's Disease Rating Scale Part 3 (UPDRS III)	—

Secondary

Measure	Time frame
Before and after the 6-week group therapy: Quality of life measured with the Parkinsons Disease Questionaire (PDQ-39) and subjective assessment of the BIG for LIFE® group in a short interview.	—

Countries

Germany

Contacts

Public ContactRebecca Schneider

Geriatriezentrum Bürgerspital

r.schneider@buergerspital.de0931-3503143

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026